Advocates press for action on children’s cancer legislation
The Hill – Children's cancer advocates pressed lawmakers to pass several pieces of legislation during a Congressional Childhood Cancer Summit Thursday.
The legislation includes:
• Reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act, which would allow for the creation of incentives for manufacturers to develop drugs to treat children's cancer. Although 12,500 children are diagnosed with cancer every year, that's only 1 percent of the national total, making pediatric drug research largely unprofitable;
